Translating Research to Real World Therapy

Cell & Gene Therapy Congress 2026

*CPD points will be awarded

Countdown to the Early Bird Registration Closing Date

Days
Hours
Minutes
Seconds

The Cell & Gene Therapy Congress 2026 brings together leading clinicians, researchers, industry partners, and policymakers to explore the latest advances shaping the future of regenerative medicine.

The programme focuses on translating scientific innovation into real-world clinical applications — from emerging therapies and manufacturing to regulatory, ethical, and safety considerations — with a dedicated emphasis on mesenchymal stem/stromal cell (MSC) developments.

Keynote Speaker

Professor John Rasko AO

Prof John Rasko is an internationally renowned clinician-scientist and leader in cell and gene therapy, whose work has significantly advanced the field globally.

Why You Should Attend

Discover the latest breakthroughs in cell and gene therapy and their clinical relevance

Understand how translational research is moving from lab to bedside

Gain insights into regulatory frameworks, safety, and ethical considerations

Explore collaboration opportunities
between academia, clinicians, and industry

Learn practical perspectives on MSC applications and implementation

Post-Congress Workshop

Needle-to-Needle® MSC Therapy for Beginners
This hands-on post-congress workshop introduces the fundamentals of needle-to-needle® mesenchymal stem cell therapy for beginners. Designed for practitioners, it focuses on practical implementation, product handling, safe infusion practices, and patient safety, guided by expert insights.
9th August 2026 (Sunday)
UTAR Sg. Long, KA Block Teaching Lab, Level 3